Selecta Biosciences, Inc. Analysis
| Analyst Ratings |
|
Average Target Price
|
6.86
|
|
Average Rating
|
4.75
|
|
# Strong Buys
|
6
|
|
# Buys
|
2
|
|
# Holds
|
0
|
|
# Sells
|
0
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2022-09-30
|
-0.01
|
-0.05
|
-0.04
|
-400.00%
|
|
2022-06-30
|
-0.08
|
0.06
|
0.14
|
175.00%
|
|
2022-03-31
|
-0.11
|
0.23
|
0.34
|
309.09%
|
|
2021-12-31
|
-0.07
|
0.03
|
0.10
|
142.86%
|
|
2021-09-30
|
-0.07
|
-0.16
|
-0.09
|
-128.57%
|
|
2021-06-30
|
-0.12
|
0.04
|
0.16
|
133.33%
|
|
2021-03-31
|
-0.12
|
-0.22
|
-0.10
|
-83.33%
|
|
2020-12-31
|
-0.12
|
-0.14
|
-0.02
|
-16.67%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2022-12-31
|
0.24
|
|
2021-12-31
|
-0.31
|
|
2020-12-31
|
-0.69
|
|
2019-12-31
|
-1.22
|
|
2018-12-31
|
-2.91
|
|
2017-12-31
|
-3.21
|
|
2016-12-31
|
-3.95
|